ACHV
Achieve Life Sciences, Inc.
stockNASDAQ
At CloseNov 9, 2026 3:59:56 PM EST
6.79USD+1.042%(+0.07)1,089,178
Pre-marketNov 9, 2026 9:21:30 AM EST
6.95USD+3.423%(+0.23)
After-hoursNov 9, 2026 4:25:30 PM EST
6.75USD-0.589%(-0.04)
Loading…
Loading…
701.10M
Healthcare
Biotechnology
CEO
Richard Stewart
HQ
Vancouver, BC, Canada
Previous Close
$6.72
Beta
1.91
52-Week High
$8.64 2026-09-03
52-Week Low
$2.62 2026-03-30
SMA 50
$7.28
SMA 200
$5.67
Avg. Vol 10D
1.30M
Avg. Vol 30D
1.35M
Avg. Vol 90D
1.42M
Relative Vol
0.81
103.10M
74.69M
72.44%
17,805,384
23.84%
13.85
56%/44%
61.56%
48.07%
0.9800%
60,286
44,754
206,700
Jul 31, 2020 · 1-for-20 (reverse)
-114.0M
-1.81
-47.0M
-844.99
Nov 10, 2026
Achieve Life Sciences reports Q3 results · 
Seeking Alpha
AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates · 
GlobeNewswire Inc.
Nov 9, 2026
Nov 2, 2026
Achieve Life Sciences Announces Granting of New Hire Inducement Awards · GlobeNewswire Inc.
Oct 23, 2026
ACHV Profile
achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
ACHV Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.73 | 2026-11-03 | +1.04% | 1.729 |
| 1M | 7.41 | 2026-10-09 | -8.23% | 1.922 |
| 3M | 6.67 | 2026-08-10 | +1.95% | 1.671 |
| 6M | 5.59 | 2026-05-11 | +21.65% | 1.305 |
| 1Y | 4.45 | 2025-11-10 | +52.81% | 1.913 |
| 2Y | 4.47 | 2024-11-11 | +52.13% | — |
| 5Y | 8.16 | 2021-11-10 | -16.67% | 1.044 |
ACHV Stock Summary
Achieve Life Sciences, Inc. (NASDAQ:ACHV) stock price today is $6.80, and today's volume is 1,089,178. The 30 day average volume is 1.35M. ACHV market cap is $701.10M with 103.10M shares outstanding.